Cargando…

YAP is a critical oncogene in human cholangiocarcinoma

Yes-associated protein (YAP), a transcriptional co-activator, has important regulatory roles in cell signaling and is dysregulated in a number of cancers. However, the role of YAP in cholangiocarcinoma (CCA) progression remains unclear. Here, we demonstrated that YAP was overexpressed in CCA cells a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Tiemin, Li, Yuejin, Wang, Jiabei, Wang, Huanlai, Liang, Yingjian, Shi, Huawen, Sun, Boshi, Yin, Dalong, Sun, Jing, Song, Ruipeng, Pan, Shangha, Sun, Yu, Jiang, Hongchi, Zheng, Tongsen, Liu, Lianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627302/ https://www.ncbi.nlm.nih.gov/pubmed/26015398

Ejemplares similares

FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling
por: Lu, Zhaoyang, et al.
Publicado: (2014)

A preliminary study of ALPPS procedure in a rat model
por: Shi, Huawen, et al.
Publicado: (2015)

LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway
por: Song, Xuan, et al.
Publicado: (2013)

The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway
por: Wang, Jiabei, et al.
Publicado: (2014)

Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma
por: Zheng, Tongsen, et al.
Publicado: (2014)

Diphenyl Difluoroketone: A Potent Chemotherapy Candidate for Human Hepatocellular Carcinoma
por: Liang, Yingjian, et al.
Publicado: (2011)

Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis
por: Han, Jihua, et al.
Publicado: (2017)

(−)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma
por: Pei, Tiemin, et al.
Publicado: (2016)

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
por: Wang, Yan, et al.
Publicado: (2018)

Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma
por: Li, Keyu, et al.
Publicado: (2016)

KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling
por: Han, Jihua, et al.
Publicado: (2018)

Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation
por: Liu, Xirui, et al.
Publicado: (2018)

In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
por: Liu, Haitao, et al.
Publicado: (2012)

STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma
por: Lan, Yaliang, et al.
Publicado: (2018)

Reduction of hepatic fibrosis by overexpression of von Hippel–Lindau protein in experimental models of chronic liver disease
por: Wang, Jizhou, et al.
Publicado: (2017)

lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2
por: Liang, Yingjian, et al.
Publicado: (2020)

PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect
por: Dan Li, et al.
Publicado: (2018)

Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12‐year retrospective study
por: Yin, Dalong, et al.
Publicado: (2020)

ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway
por: Cui, Yifeng, et al.
Publicado: (2020)

NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways
por: Meng, Fanzheng, et al.
Publicado: (2019)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

YAP in pancreatic cancer: oncogenic role and therapeutic strategy
por: Mao, Wenhao, et al.
Publicado: (2021)

Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
por: Zheng, Tongsen, et al.
Publicado: (2013)

YAP-associated chromosomal instability and cholangiocarcinoma in mice
por: Rizvi, Sumera, et al.
Publicado: (2017)

BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function
por: Yue, Xuetian, et al.
Publicado: (2015)

Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer
por: Sun, Ting, et al.
Publicado: (2021)

Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression Analysis
por: Bai, Qingquan, et al.
Publicado: (2020)

The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
por: Luo, Juan, et al.
Publicado: (2023)

NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
por: Lu, Shounan, et al.
Publicado: (2022)

Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
por: Qian, Meijia, et al.
Publicado: (2021)

A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
por: Liang, Shuhang, et al.
Publicado: (2021)

YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo
por: Sun, Dan, et al.
Publicado: (2016)

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells
por: Wang, Yongwei, et al.
Publicado: (2012)

Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development
por: Pocaterra, Arianna, et al.
Publicado: (2021)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

An Updated Understanding of the Role of YAP in Driving Oncogenic Responses
por: Morciano, Giampaolo, et al.
Publicado: (2021)

Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
por: Pu, Xiaohong, et al.
Publicado: (2023)

Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
por: Tóth, Marcell, et al.
Publicado: (2021)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9atr0dk6nnl2mkf5bjo3iig0sh